{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:34:49Z","timestamp":1786980889212,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"grant-in-aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["23592446"],"award-info":[{"award-number":["23592446"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10585-015-9751-0","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T11:55:02Z","timestamp":1444132502000},"page":"789-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Takeshi","family":"Hisamatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahiru","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Kozasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Kitadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"issue":"1","key":"9751_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11\u201330","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"9751_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J et al (2010) Cancer statistics. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"9751_CR3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0959-8049(98)00326-8","volume":"34","author":"G Gatta","year":"1998","unstructured":"Gatta G, Lasota MB, Verdecchia A, EUROCARE Working Group (1998) Survival of European women with gynaecological tumours, during the period 1978-1989. Eur J Cancer 34(14):2218\u20132225","journal-title":"Eur J Cancer"},{"issue":"26","key":"9751_CR4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","volume":"365","author":"RA Burger","year":"2011","unstructured":"Burger RA, Brady MF, Bookman MA et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365(26):2473\u20132483","journal-title":"N Engl J Med"},{"issue":"4","key":"9751_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3802\/jgo.2014.25.4.279","volume":"25","author":"M Mikami","year":"2014","unstructured":"Mikami M (2014) Role of lymphadenectomy for ovarian cancer. J Gynecol Oncol 25(4):279\u2013281","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"9751_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.AOG.0000249610.95885.ef","volume":"109","author":"JK Chan","year":"2007","unstructured":"Chan JK, Munro EG, Cheung MK et al (2007) Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109(1):12\u201319","journal-title":"Obstet Gynecol"},{"issue":"11","key":"9751_CR7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17(11):1371\u20131380","journal-title":"Nat Med"},{"issue":"11","key":"9751_CR8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1080\/00016340802478158","volume":"87","author":"HS Kim","year":"2008","unstructured":"Kim HS, Park NH, Chung HH et al (2008) Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Acta Obstet Gynecol Scand 87(11):1136\u20131142","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"9751_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2003.09.002","volume":"92","author":"AJ Li","year":"2004","unstructured":"Li AJ, Madden AC, Cass I et al (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92(1):211\u2013214","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9751_CR10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","volume":"122","author":"CA Powless","year":"2011","unstructured":"Powless CA, Aletti GD, Bakkum-Gamez JN et al (2011) Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol 122(3):536\u2013540","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9751_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.31","volume":"1","author":"K Matsuo","year":"2012","unstructured":"Matsuo K, Sheridan TB, Yoshino K et al (2012) Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med 1(2):156\u2013164","journal-title":"Cancer Med"},{"issue":"1","key":"9751_CR12","first-page":"93","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Obermair A, Schindl M et al (2001) Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res 7(1):93\u201397","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9751_CR13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/IGC.0b013e318269139b","volume":"22","author":"SK Weber","year":"2012","unstructured":"Weber SK, Sauerwald A, Polcher M et al (2012) Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer. Int J Gynecol Cancer 22(8):1442\u20131448","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"9751_CR14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajpath.2013.12.030","volume":"184","author":"A Decio","year":"2014","unstructured":"Decio A, Taraboletti G, Patton V et al (2014) Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms. Am J Pathol 184(4):1050\u20131061","journal-title":"Am J Pathol"},{"issue":"9","key":"9751_CR15","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1158\/1078-0432.CCR-04-1148","volume":"11","author":"M Ueda","year":"2005","unstructured":"Ueda M, Hung YC, Terai Y et al (2005) Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res 11(9):3225\u20133232","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9751_CR16","doi-asserted-by":"crossref","first-page":"e55309","DOI":"10.1371\/journal.pone.0055309","volume":"8","author":"D Cheng","year":"2013","unstructured":"Cheng D, Liang B, Li Y (2013) Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PLoS One 8(2):e55309","journal-title":"PLoS One"},{"issue":"22","key":"9751_CR17","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/1078-0432.CCR-08-0818","volume":"14","author":"M Kodama","year":"2008","unstructured":"Kodama M, Kitadai Y, Tanaka M et al (2008) Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res 14(22):7205\u20137214","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9751_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jcp.2004.019174","volume":"58","author":"MI Koukourakis","year":"2005","unstructured":"Koukourakis MI, Giatromanolaki A, Sivridis E et al (2005) LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 58(2):202\u2013206","journal-title":"J Clin Pathol"},{"issue":"4","key":"9751_CR19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jvs.2005.01.015","volume":"41","author":"SM Bauer","year":"2005","unstructured":"Bauer SM, Bauer RJ, Liu ZJ et al (2005) Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg 41(4):699\u2013707","journal-title":"J Vasc Surg"},{"issue":"1","key":"9751_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejca.2003.08.008","volume":"40","author":"Y Tamada","year":"2004","unstructured":"Tamada Y, Aoki D, Nozawa S et al (2004) Model for paraaortic lymph node metastasis produced by orthotopic implantation of ovarian carcinoma cells in athymic nude mice. Eur J Cancer 40(1):158\u2013163","journal-title":"Eur J Cancer"},{"issue":"9","key":"9751_CR21","first-page":"3065","volume":"118","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Ma L, Teruya-Feldstein J et al (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118(9):3065\u20133074","journal-title":"J Clin Invest"},{"issue":"8","key":"9751_CR22","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI37539","volume":"120","author":"F Nicolantonio Di","year":"2010","unstructured":"Di Nicolantonio F, Arena S, Tabernero J et al (2010) Deregulation of the PI3\u00a0K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 120(8):2858\u20132866","journal-title":"J Clin Invest"},{"issue":"5","key":"9751_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-08-1372","volume":"15","author":"K Bogos","year":"2009","unstructured":"Bogos K, Renyi-Vamos F, Dobos J et al (2009) High VEGFR-3-positive circulating lymphatic\/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res 15(5):1741\u20131746","journal-title":"Clin Cancer Res"},{"issue":"13","key":"9751_CR24","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood-2005-01-0226","volume":"106","author":"P Religa","year":"2005","unstructured":"Religa P, Cao R, Bjorndahl M et al (2005) Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106(13):4184\u20134190","journal-title":"Blood"},{"issue":"1","key":"9751_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","volume":"137","author":"S Mabuchi","year":"2015","unstructured":"Mabuchi S, Kuroda H, Takahashi R et al (2015) The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer. Gynecol Oncol 137(1):173\u2013179","journal-title":"Gynecol Oncol"},{"issue":"5","key":"9751_CR26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1349-7006.2007.00439.x","volume":"98","author":"S Kobayashi","year":"2007","unstructured":"Kobayashi S, Kishimoto T, Kamata S et al (2007) Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci 98(5):726\u2013733","journal-title":"Cancer Sci"},{"issue":"1","key":"9751_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2002-03-0755","volume":"101","author":"P Salven","year":"2003","unstructured":"Salven P, Mustjoki S, Alitalo R et al (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic\/vascular endothelial precursor cells. Blood 101(1):168\u2013172","journal-title":"Blood"},{"issue":"3","key":"9751_CR28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jcmm.12233","volume":"18","author":"YZ Tan","year":"2014","unstructured":"Tan YZ, Wang HJ, Zhang MH et al (2014) CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells. J Cell Mol Med 18(3):422\u2013433","journal-title":"J Cell Mol Med"},{"issue":"14","key":"9751_CR29","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1093\/emboj\/18.14.3964","volume":"18","author":"T Asahara","year":"1999","unstructured":"Asahara T, Takahashi T, Masuda H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18(14):3964\u20133972","journal-title":"EMBO J"},{"issue":"22","key":"9751_CR30","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-10-3192","volume":"71","author":"V Patel","year":"2011","unstructured":"Patel V, Marsh CA, Dorsam RT et al (2011) Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 71(22):7103\u20137112","journal-title":"Cancer Res"},{"issue":"9","key":"9751_CR31","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1245\/s10434-010-1040-1","volume":"17","author":"K Hirashima","year":"2010","unstructured":"Hirashima K, Baba Y, Watanabe M et al (2010) Phosphorylated mTOR expression is associated with poor prognosis for patients with esophageal squamous cell carcinoma. Ann Surg Oncol 17(9):2486\u20132493","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9751_CR32","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-08-2138","volume":"15","author":"G Yu","year":"2009","unstructured":"Yu G, Wang J, Chen Y et al (2009) Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res 15(5):1821\u20131829","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9751_CR33","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/0008-5472.CAN-06-4490","volume":"67","author":"S Mabuchi","year":"2007","unstructured":"Mabuchi S, Altomare DA, Connolly DC et al (2007) RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res 67(6):2408\u20132413","journal-title":"Cancer Res"},{"issue":"14","key":"9751_CR34","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","volume":"13","author":"S Mabuchi","year":"2007","unstructured":"Mabuchi S, Altomare DA, Cheung M et al (2007) RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res 13(14):4261\u20134270","journal-title":"Clin Cancer Res"},{"issue":"15","key":"9751_CR35","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/0008-5472.CAN-05-0408","volume":"65","author":"J Lin","year":"2005","unstructured":"Lin J, Lalani AS, Harding TC et al (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65(15):6901\u20136909","journal-title":"Cancer Res"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9751-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-015-9751-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-015-9751-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:40:05Z","timestamp":1559227205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-015-9751-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9751"],"URL":"https:\/\/doi.org\/10.1007\/s10585-015-9751-0","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}